Company Filing History:
1 out of 52 
1 out of 832,843 Years Active: 2015-2017
Title: Bjoern Schlummer: Innovator in Pharmaceutical Chemistry
Introduction
Bjoern Schlummer is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of neurological disorders.
Latest Patents
Bjoern Schlummer holds two patents that focus on chemical compounds useful as intermediates for preparing catechol-O-methyltransferase inhibitors. His latest patents include a methylated intermediate that can be demethylated to provide an inhibitor of catechol-O-methyltransferase. This compound is particularly useful in the treatment of Parkinson's disease. Additionally, he has disclosed methods for making and using this intermediate, showcasing his innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Bjoern has worked with various companies, including Bial-Portela & Ca S.A. His work has been instrumental in advancing the understanding and treatment of diseases related to catechol-O-methyltransferase.
Collaborations
Bjoern has collaborated with notable professionals in his field, including Domenico Russo and Laszlo Erno Kiss. These collaborations have further enriched his research and development efforts.
Conclusion
Bjoern Schlummer's contributions to pharmaceutical chemistry and his innovative patents highlight his commitment to improving treatments for neurological disorders. His work continues to inspire advancements in the field.